Literature DB >> 25856832

A comparison of tests for Hardy-Weinberg equilibrium.

T H Emigh.   

Abstract

The various tests for the goodness of fit of a population to Hardy-Weinberg equilibrium are compared with respect to their power and the accuracy of their distributional approximations. The tests are similar in terms of power. However, when one or more alleles are rare (with frequencies of less than .45 to .21 for n = 10 and 200, respectively) some of the tests are not able to detect outbreeding. When all but one allele are rare (frequencies of less than .40 to .15 for n = 10 and 200, respectively) none of the tests are able to detect outbreeding. In terms of distributional assumptions, there are two situations: (i) Test of hypothesis (when a preset significance level is chosen and the null hypothesis accepted or rejected at that level); here the chi square test with conditional expectations, the Freeman-Tukey test and the Mantel-Li test, all without continuity correction, were found to be best; they were closely followed by the chi square test and conditional chi square test, both with a continuity correction of 1/4, and by the Elston-Forthofer average test. (ii) Test of significance (when the obtained level of significance is used as strength against the null hypothesis); here the chi square test and conditional chi square test, both with a continuity correction of 1/4, and the average test were found to be best.

Year:  1980        PMID: 25856832

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  57 in total

1.  Common variation in fatty acid genes and resuscitation from sudden cardiac arrest.

Authors:  Catherine O Johnson; Rozenn N Lemaitre; Carol E Fahrenbruch; Stephanie Hesselson; Nona Sotoodehnia; Barbara McKnight; Kenneth M Rice; Pui-Yan Kwok; David S Siscovick; Thomas D Rea
Journal:  Circ Cardiovasc Genet       Date:  2012-06-01

2.  Analytical methods for immunogenetic population data.

Authors:  Steven J Mack; Pierre-Antoine Gourraud; Richard M Single; Glenys Thomson; Jill A Hollenbach
Journal:  Methods Mol Biol       Date:  2012

3.  The number of markers in the HapMap project: some notes on chi-square and exact tests for Hardy-Weinberg equilibrium.

Authors:  Jan Graffelman
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

4.  Impact of Hardy-Weinberg equilibrium deviation on allele-based risk effect of genetic association studies and meta-analysis.

Authors:  Elias Zintzaras
Journal:  Eur J Epidemiol       Date:  2010-06-05       Impact factor: 8.082

Review 5.  LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.

Authors:  Yu Tong; Jing Liao; Yuan Zhang; Jing Zhou; Hengyu Zhang; Meng Mao
Journal:  Mol Vis       Date:  2010-10-05       Impact factor: 2.367

6.  Hardy-Weinberg testing of a single homozygous genotype.

Authors:  John J Chen; Tao Duan; Richard Single; Kristie Mather; Glenys Thomson
Journal:  Genetics       Date:  2005-05-23       Impact factor: 4.562

7.  An angiotensin converting enzyme haplotype predicts survival in patients with end stage renal disease.

Authors:  James B Wetmore; Kirsten L Johansen; Saunak Sen; Adriana M Hung; David H Lovett
Journal:  Hum Genet       Date:  2006-06-22       Impact factor: 4.132

8.  PyPop update--a software pipeline for large-scale multilocus population genomics.

Authors:  A K Lancaster; R M Single; O D Solberg; M P Nelson; G Thomson
Journal:  Tissue Antigens       Date:  2007-04

9.  A discussion on significance indices for contingency tables under small sample sizes.

Authors:  Natalia L Oliveira; Carlos A de B Pereira; Marcio A Diniz; Adriano Polpo
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

10.  Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women.

Authors:  Yifan Huang; Amy Trentham-Dietz; Montserrat García-Closas; Polly A Newcomb; Linda Titus-Ernstoff; John M Hampton; Stephen J Chanock; Jonathan L Haines; Kathleen M Egan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-17       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.